Free tool
FAERS Monitor: Sublocade
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 209819 or its brand name (Sublocade, Buprenorphine). Reports on generic versions are filed under their own applications.
Reports
29,342
Serious
20,423
70% of reports
Hospitalization
6,667
Death reported
5,267
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug dependence4,471
- drug withdrawal syndrome2,405
- drug abuse2,355
- overdose2,229
- pain2,122
- toxicity to various agents1,653
- death1,645
- drug ineffective1,606
- nausea1,468
- emotional distress1,255
- vomiting1,186
- off label use1,156
- maternal exposure during pregnancy1,096
- anxiety1,035
- somnolence986
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 3 |
| 2005 | 34 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 30 |
| 2010 | 83 |
| 2011 | 231 |
| 2012 | 384 |
| 2013 | 322 |
| 2014 | 355 |
| 2015 | 572 |
| 2016 | 572 |
| 2017 | 790 |
| 2018 | 2,159 |
| 2019 | 3,435 |
| 2020 | 2,961 |
| 2021 | 3,566 |
| 2022 | 3,860 |
| 2023 | 2,520 |
| 2024 | 2,722 |
| 2025 | 2,809 |
| 2026 | 1,927 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,024,817 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| drug abuseSignal | 2,355 | 20.8 | 20.0 | 43,377 |
| drug dependenceSignal | 4,471 | 20.5 | 19.9 | 81,112 |
| drug withdrawal syndromeSignal | 2,405 | 20.2 | 19.4 | 42,783 |
| maternal exposure during pregnancySignal | 1,096 | 8.9 | 8.4 | 7,629 |
| emotional distressSignal | 1,255 | 7.5 | 7.1 | 7,028 |
| overdoseSignal | 2,229 | 7.5 | 7.2 | 12,492 |
| toxicity to various agentsSignal | 1,653 | 7.1 | 6.8 | 8,619 |
| somnolenceSignal | 986 | 3.5 | 3.3 | 1,787 |
| anxietySignal | 1,035 | 2.6 | 2.5 | 1,039 |
| painSignal | 2,122 | 2.5 | 2.4 | 1,925 |
| vomiting | 1,186 | 1.8 | 1.7 | 438 |
| death | 1,645 | 1.4 | 1.3 | 170 |
| nausea | 1,468 | 1.3 | 1.3 | 124 |
| off label use | 1,156 | 0.9 | 0.9 | 4 |
| drug ineffective | 1,606 | 0.9 | 0.8 | 31 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.